Toby Eyre
Churchill Hospital, Oxford, United Kingdom · NCRI UK · University of Oxford
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Toby Eyre as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05004064 · Acalabrutinib and Rituximab in Previously Untreated Mantle Cell LymphomaUniversity College, London · active not recruiting · Mantle Cell Lymphoma · principal investigator
- Ph2NCT04802590 · Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell LymphomaThe Lymphoma Academic Research Organisation · active not recruiting · Mantle Cell Lymphoma · principal investigator
- Ph2NCT03899337 · A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's SyndromeUniversity of Birmingham · active not recruiting · Richter Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 20:55 UTC. The ranking covers the 200 most relevant of 31 PubMed records, and a shared surname and initials can bring in a namesake. All 31 on PubMed
- Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.Lancet · 2021399 citationsRCR 21.4
- 268 citationsRCR 10.8
- 213 citationsRCR 20.0
- Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.N Engl J Med · 2024159 citationsRCR 20.5
- Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.Blood · 202183 citationsRCR 4.2
- NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.Br J Haematol · 201663 citationsRCR 1.9
- Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1-2 study.Lancet Haematol · 202157 citationsRCR 2.9
- Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.N Engl J Med · 202546 citationsRCR 9.6
- 43 citationsRCR 1.2
- 39 citationsRCR 4.9